Skip to main content

Table 1 Baseline characteristics of all study participants

From: A novel diagnostic model for tuberculous meningitis using Bayesian latent class analysis

 

Any test

ZN-Smear

MGIT

Xpert

Characteristic

N = 659

Positive, N = 138a

Negative, N = 217a

Missing, N = 304a

Positive, N = 125a

Negative, N = 230a

Positive, N = 85a

Negative, N = 270a

Positive, N = 74a

Negative, N = 281a

Age (year(s))

659

42; 39 (29, 51)

42; 40 (27, 56)

42; 40 (26, 56)

42; 39 (29, 51)

42; 40 (27, 56)

40; 39 (29, 48)

43; 40 (28, 56)

40; 37 (29, 48)

43; 40 (28, 56)

HIV positive

448

33 (27%)

8 (5.2%)

9 (5.3%)

31 (27%)

10 (6.1%)

26 (33%)

15 (7.5%)

26 (37%)

15 (7.2%)

 - Missing

 

14

63

134

11

66

6

71

4

73

Symptom duration (day(s))

633

15; 12 (8, 16)

12; 8 (5, 14)

9; 5 (3, 8)

15; 12 (8, 15)

12; 8 (5, 14)

18; 14 (10, 20)

12; 8 (5, 14)

18; 14 (10, 21)

12; 8 (5, 14)

 - Missing

 

8

9

9

7

10

7

10

7

10

TB-suggested systemic symptoms

394

53 (58%)

42 (31%)

20 (12%)

49 (60%)

46 (32%)

36 (68%)

59 (34%)

33 (70%)

62 (35%)

 - Missing

 

47

83

135

44

86

32

98

27

103

Noticed TB contact within the last 12 months

659

7 (5.1%)

3 (1.4%)

0 (0%)

7 (5.6%)

3 (1.3%)

4 (4.7%)

6 (2.2%)

4 (5.4%)

6 (2.1%)

Focal neurological deficit

643

24 (18%)

27 (13%)

28 (9.4%)

23 (19%)

28 (13%)

17 (20%)

34 (13%)

16 (22%)

35 (13%)

 - Missing

 

4

7

5

4

7

2

9

2

9

Cranial nerve palsy

659

31 (22%)

27 (12%)

24 (7.9%)

29 (23%)

29 (13%)

25 (29%)

33 (12%)

23 (31%)

35 (12%)

Glasgow Coma Score

638

12; 12 (10, 15)

12; 12 (10, 14)

12; 12 (10, 13)

12; 12 (10, 15)

12; 12 (10, 14)

11; 11 (10, 14)

12; 13 (10, 15)

11; 11 (9, 14)

12; 13 (10, 15)

 - Missing

 

1

4

16

1

4

1

4

1

4

X-ray pulmonary TB (excluding miliary TB)

659

22 (16%)

5 (2.3%)

4 (1.3%)

20 (16%)

7 (3.0%)

17 (20%)

10 (3.7%)

18 (24%)

9 (3.2%)

X-ray miliary TB

659

4 (2.9%)

0 (0%)

1 (0.3%)

4 (3.2%)

0 (0%)

4 (4.7%)

0 (0%)

3 (4.1%)

1 (0.4%)

CSF lymphocyte count (cell(s)/mm3)

656

228; 153 (82, 302)

278; 80 (13, 291)

270; 48 (5, 261)

220; 152 (81, 292)

279; 90 (14, 293)

237; 152 (81, 329)

265; 102 (21, 290)

212; 123 (57, 285)

271; 110 (23, 293)

 - Missing

 

0

0

3

0

0

0

0

0

0

CSF WCC (cell(s)/mm3)

656

481; 300 (163, 559)

708; 140 (18, 460)

1,940; 68 (8, 856)

483; 280 (160, 564)

693; 164 (24, 478)

492; 330 (190, 519)

659; 166 (32, 479)

485; 300 (184, 614)

655; 176 (35, 475)

 - Missing

 

0

0

3

0

0

0

0

0

0

CSF eosinophil count (cell(s)/mm3)

658

0; 0 (0, 0)

14; 0 (0, 0)

5; 0 (0, 0)

0; 0 (0, 0)

13; 0 (0, 0)

0; 0 (0, 0)

11; 0 (0, 0)

0; 0 (0, 0)

11; 0 (0, 0)

 - Missing

 

0

0

1

0

0

0

0

0

0

CSF RBC Count (cell(s)/mm3)

659

874; 25 (2, 123)

2,040; 12 (0, 324)

1,673; 18 (0, 1,000)

341; 22 (2, 90)

2,263; 14 (0, 390)

1,164; 25 (0, 140)

1,719; 14 (0, 300)

267; 21 (0, 105)

1,934; 16 (0, 300)

CSF protein (g/l)

657

2.44; 1.79 (1.18, 2.45)

1.48; 0.88 (0.46, 1.75)

1.73; 0.73 (0.37, 1.98)

2.49; 1.86 (1.21, 2.46)

1.50; 0.91 (0.46, 1.82)

2.26; 1.89 (1.35, 2.50)

1.72; 1.01 (0.50, 1.93)

2.85; 1.88 (1.51, 2.39)

1.59; 1.00 (0.51, 1.97)

 - Missing

 

0

0

2

0

0

0

0

0

0

CSF lactate (mmol/l)

657

5.8; 5.4 (3.8, 7.8)

4.1; 3.1 (2.3, 4.6)

5.6; 3.0 (2.2, 6.8)

5.9; 5.4 (3.8, 7.8)

4.2; 3.2 (2.3, 5.0)

6.5; 6.1 (4.4, 8.0)

4.3; 3.4 (2.3, 5.0)

6.8; 6.6 (5.2, 8.3)

4.3; 3.4 (2.3, 5.0)

 - Missing

 

0

0

2

0

0

0

0

0

0

CSF glucose (mmol/l)

657

2.21; 1.97 (1.34, 2.80)

3.50; 3.51 (2.64, 4.31)

3.55; 3.76 (2.67, 4.54)

2.14; 1.97 (1.30, 2.76)

3.47; 3.49 (2.59, 4.30)

2.00; 1.76 (1.27, 2.29)

3.32; 3.33 (2.47, 4.08)

1.79; 1.67 (1.19, 2.18)

3.32; 3.31 (2.42, 4.08)

 - Missing

 

0

0

2

0

0

0

0

0

0

Paired blood glucose (mmol/l)

651

6.55; 6.41 (5.80, 7.26)

6.96; 6.53 (5.44, 7.51)

7.17; 6.54 (5.45, 8.13)

6.51; 6.40 (5.78, 7.20)

6.96; 6.53 (5.46, 7.52)

6.60; 6.53 (5.78, 7.28)

6.87; 6.48 (5.52, 7.46)

6.49; 6.40 (5.70, 7.14)

6.89; 6.49 (5.53, 7.50)

 - Missing

 

1

2

5

1

2

1

2

1

2

Cryptococcal antigen/Indian ink + 

572

1 (0.7%)

5 (2.4%)

13 (5.8%)

1 (0.8%)

5 (2.3%)

1 (1.2%)

5 (1.9%)

1 (1.4%)

5 (1.8%)

 - Missing

 

1

8

78

1

8

0

9

0

9

Positive CSF Gram stain

644

0 (0%)

7 (3.2%)

37 (13%)

0 (0%)

7 (3.1%)

0 (0%)

7 (2.6%)

0 (0%)

7 (2.5%)

 - Missing

 

5

1

9

3

3

3

3

1

5

Fever

659

134 (97%)

203 (94%)

276 (91%)

121 (97%)

216 (94%)

82 (96%)

255 (94%)

71 (96%)

266 (95%)

Headache

606

127 (96%)

162 (81%)

215 (79%)

115 (96%)

174 (82%)

79 (98%)

210 (83%)

68 (96%)

221 (84%)

 - Missing

 

6

16

31

5

17

4

18

3

19

Neck stiffness

633

75 (56%)

114 (54%)

158 (55%)

67 (56%)

122 (54%)

46 (55%)

143 (54%)

39 (54%)

150 (55%)

 - Missing

 

5

4

17

5

4

2

7

2

7

Psychosis

647

4 (2.9%)

32 (15%)

63 (21%)

3 (2.4%)

33 (15%)

3 (3.6%)

33 (12%)

2 (2.7%)

34 (12%)

 - Missing

 

2

3

7

2

3

1

4

1

4

  1. In the “Any test” stratum: positive where at least one amongst ZN-Smear, MGIT, or Xpert is positive. ZN-Smear, MGIT, and Xpert are the sub-populations where the respective microbacterial test was performed (N = 355)
  2. aMean; Median (1st, 3rd quartiles) for numeric variables; n (%) for categorical variables